CorTec
Key Facts
| Invested since | 2011 |
| Based in | Baden-Württemberg |
About the company
We are thinking ahead, developing tomorrow’s neurotechnology today.
It is our great strength that our technology derives from one single thought – from the basic idea up to its subsequent therapeutic use. This way, we create innovations regarding therapy, rehabilitation, and assistive technologies.
Our most important product is CorTec Brain Interchange, an implantable technology that measures and stimulates brain activity in long-term use.
CorTec Brain Interchange controls itself: The system measures the brain’s activity and thus the effect of its stimulation. It then aligns its further activities with the measured data.
Contrary to other neurotechnological implants currently on the market, CorTec Brain Interchange determines the respective therapeutic demand in direct communication with the brain and thus allows for a gentle treatment.
CorTec Brain Interchange consists of 3 components:
- Up to two multi-channel electrodes on the brain surface plus eventually two depth electrodes, connected with
- an intelligent implant that communicates via the skin with
- a software which reads the measured data and controls the application.
The electrode component oft he implant is at the same time our first product that we are already selling into the research market and also to other companies as subcomponent of their own products. CE and FDA approval are in preparation.
CorTec is a limited liability company that was founded in Freiburg, Germany, in September 2010. In summer of 2018 CorTec moved into new premises closeby the Airport Campus of the University of Freiburg including own clean room facilities. Thus, a continued growth of the company is ensured as well as the existing interconnection with science and research.
CorTec in the news
Zum Artikel
CorTec On The Way To The Future Of Neurotechnology: Company Closes Second Financing Round
More startups from Life Sciences
Akribion Therapeutics is developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion. Our G-dase® E nuclease has the ability to kill cells by shredding DNA and RNA, but only …
Rigontec GmbH is a preclinical biotech company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases. Rigontec’s lead compound ImOl100 targets a novel receptor of the innate immune …
Draupnir Bio is a spin out company, from Aarhus University and the Max-Planck Society and establishing itself at the forefront of protein degradation. Draupnir’s novel and proprietary platform technology is …
Abalos Therapeutics has harnessed the unique immune stimulation of the arenavirus to develop a novel anti-cancer approach that provides the full breadth of the immune system’s power specifically against cancer …
multiBIND develops innovative solutions for molecular biology, healthcare and agriculture. bioDECONT® and bioCLEAN represent biocompatible disinfection and decontamination in laboratories, hospitals and agriculture.
DyNAbind is offering innovative drug discovery products and services based on its proprietary Dynamic DNA-Encoded Library (D-DEL) technology platform. With D-DEL, DyNAbind can simultaneously screen hundreds of millions of compounds …
Carelane is a health tech startup focused on addressing the inefficiencies in clinical trials by integrating multiple essential functions into a single, streamlined system, thereby digitizing study protocols and processes. …
PreOmics develops and provides innovative technologies for customers around the world for mass spectrometry (MS) – based proteomics using cutting-edge technologies to support researchers in their protein analysis needs.
iAtros is a digital heart clinic and a fully integrated platform, providing better medical care for patients with cardiovascular problems around the clock. Among other services, iATROS offers smart sensor …
Humedics markets a system for bedside and instantaneous measurement of liver function. Patented device, consumables and a diagnostic drug allow an optimal market offering.
C-mo Medical Solutions is an award-winning Digital Health start-up that develops solutions for the diagnosis and management of cough-incident medical conditions. The company’s mission is to unravel the clinical potential …
